ArticlePharmaceuticals (Basel, Switzerland)2022

Pulmonary Targeting of Levofloxacin Using Microsphere-Based Dry Powder Inhalation.

Turki Al Hagbani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.